Evidence map›Paper›PMID 32870937›Full record

ArticlePloS one2020

Perioperative anticoagulation in patients with intracranial meningioma: No increased risk of intracranial hemorrhage?

Florian Wilhelmy, Annika Hantsche, Tim Wende, Johannes Kasper, Vera Reuschel, Clara Frydrychowicz, Stefan Rasche, Dirk Lindner, Jürgen Meixensberger

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Meningioma resection and venous thromboembolism incidence, management, and outcomes.Research and practice in thrombosis and haemostasis · 2023
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Florian WilhelmyDepartment of Neurosurgery, University Hospital Leipzig, Leipzig, Germany.ORCID 0000-0002-1304-346X
Annika HantscheDepartment of Neurosurgery, University Hospital Leipzig, Leipzig, Germany.
Tim WendeDepartment of Neurosurgery, University Hospital Leipzig, Leipzig, Germany.ORCID 0000-0002-8634-8897
Johannes KasperDepartment of Neurosurgery, University Hospital Leipzig, Leipzig, Germany.
Vera ReuschelDivision of Neuroradiology, University Hospital Leipzig, Leipzig, Germany.
Clara FrydrychowiczDivision of Neuropathology, University Hospital Leipzig, Leipzig, Germany.
Stefan RascheDepartment of Anesthesiology and Intensive Care, University Hospital Leipzig, Leipzig, Germany.
Dirk LindnerDepartment of Neurosurgery, University Hospital Leipzig, Leipzig, Germany.
Jürgen MeixensbergerDepartment of Neurosurgery, University Hospital Leipzig, Leipzig, Germany.
University Hospital Leipzig · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveAnticoagulation (AC) is a critical topic in perioperative and post-bleeding management. Nevertheless, there is a lack of data about the safe, judicious use of prophylactic and therapeutic anticoagulation with regard to risk factors and the cause and modality of brain tissue damage as well as unfavorable outcomes such as postoperative hemorrhage (PH) and thromboembolic events (TE) in neurosurgical patients. We therefore present retrospective data on perioperative anticoagulation in meningioma surgery.

methodsData of 286 patients undergoing meningioma surgery between 2006 and 2018 were analyzed. We followed up on anticoagulation management, doses and time points of first application, laboratory values, and adverse events such as PH and TE. Pre-existing medication and hemostatic conditions were evaluated. The time course of patients was measured as overall survival, readmission within 30 days after surgery, as well as Glasgow Outcome Scale (GOS) and modified Rankin Scale (mRS). Statistical analysis was performed using multivariate regression.

resultsWe carried out AC with Fraxiparin and, starting in 2015, Tinzaparin in weight-adapted recommended prophylactic doses. Delayed (216 ± 228h) AC was associated with a significantly increased rate of TE (p = 0.026). Early (29 ± 21.9h) prophylactic AC, on the other hand, did not increase the risk of PH. We identified additional risk factors for PH, such as blood pressure maxima, steroid treatment, and increased white blood cell count. Patients' outcome was affected more adversely by TE than PH (+3 points in modified Rankin Scale in TE vs. +1 point in PH, p = 0.001).

conclusionEarly prophylactic AC is not associated with an increased rate of PH. The risks of TE seem to outweigh those of PH. Early postoperative prophylactic AC in patients undergoing intracranial meningioma resection should be considered.

Indexed as

AgedAnticoagulantsDrug Administration ScheduleFemaleGermanyHumansIntracranial HemorrhagesLogistic ModelsMaleMeningeal NeoplasmsMeningiomaMiddle AgedPerioperative CarePostoperative HemorrhageRetrospective StudiesRisk FactorsAnticoagulants

Identifiers

PMID32870937
PMCPMC7462284
OpenAlexW3082164949

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.